These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35320762)

  • 1. Knowledge about atrial fibrillation and anticoagulation affects the risk of clinical outcomes.
    Konieczyńska M; Bijak P; Malinowski KP; Undas A
    Thromb Res; 2022 May; 213():105-112. PubMed ID: 35320762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low bleeding acceptance is associated with increased death risk in patients with atrial fibrillation on oral anticoagulation.
    Rusin G; Konieczyńska M; Natorska J; Malinowski KP; Undas A
    J Thromb Thrombolysis; 2024 Jan; 57(1):155-163. PubMed ID: 37598109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
    O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
    J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge.
    Kea B; Waites BT; Lin A; Raitt M; Vinson DR; Ari N; Welle L; Sill A; Button D; Sun BC
    West J Emerg Med; 2020 Jun; 21(4):924-934. PubMed ID: 32726266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor bleeding affects the level of knowledge in patients with atrial fibrillation on oral anticoagulant therapy.
    Metzgier-Gumiela A; Skonieczny G; Konieczyńska M; Desteghe L; Heidbuchel H; Undas A
    Int J Clin Pract; 2020 Jun; 74(6):e13483. PubMed ID: 32003070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S; Lane DA; Buller H; Lip GY
    Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
    Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
    Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation after intracerebral hemorrhage in patients with atrial fibrillation: between Scylla and Charybdis.
    Abrantes CS; Pintalhão M; Tavares S; Fonseca L; Chaves PC
    Neurol Sci; 2022 Apr; 43(4):2441-2448. PubMed ID: 34542785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke.
    Redfors B; Gray WA; Lee RJ; Ellenbogen KA; Bonafede M; Ben-Yehuda O
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1369-1376. PubMed ID: 29759666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk.
    Verbrugge FH; Martin AC; Siegal D; Pieper K; Illingworth L; Camm AJ; Fox KAA
    Heart; 2020 Jun; 106(11):845-851. PubMed ID: 31806700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.